Forecasting the Effects of the New SARS-CoV-2 Variant in Europe

Due to the emergence of a new SARS-CoV-2 variant, we use a previous model to simulate the behaviour of this new SARS-CoV-2 variant. The analysis and simulations are performed for Europe, in order to provide a global analysis of the pandemic. In this context, numerical results are obtained in the fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Area, Iván, Nieto, Juan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106412/
https://www.ncbi.nlm.nih.gov/pubmed/34012360
http://dx.doi.org/10.1155/2021/5553240
_version_ 1783689772058804224
author Area, Iván
Nieto, Juan J.
author_facet Area, Iván
Nieto, Juan J.
author_sort Area, Iván
collection PubMed
description Due to the emergence of a new SARS-CoV-2 variant, we use a previous model to simulate the behaviour of this new SARS-CoV-2 variant. The analysis and simulations are performed for Europe, in order to provide a global analysis of the pandemic. In this context, numerical results are obtained in the first 100 days of the pandemic assuming an infectivity of 70%, 56%, and 35%, respectively, higher for the new SAR-CoV-2 variant, as compared with the real data.
format Online
Article
Text
id pubmed-8106412
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-81064122021-05-18 Forecasting the Effects of the New SARS-CoV-2 Variant in Europe Area, Iván Nieto, Juan J. ScientificWorldJournal Research Article Due to the emergence of a new SARS-CoV-2 variant, we use a previous model to simulate the behaviour of this new SARS-CoV-2 variant. The analysis and simulations are performed for Europe, in order to provide a global analysis of the pandemic. In this context, numerical results are obtained in the first 100 days of the pandemic assuming an infectivity of 70%, 56%, and 35%, respectively, higher for the new SAR-CoV-2 variant, as compared with the real data. Hindawi 2021-05-04 /pmc/articles/PMC8106412/ /pubmed/34012360 http://dx.doi.org/10.1155/2021/5553240 Text en Copyright © 2021 Iván Area and Juan J. Nieto. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Area, Iván
Nieto, Juan J.
Forecasting the Effects of the New SARS-CoV-2 Variant in Europe
title Forecasting the Effects of the New SARS-CoV-2 Variant in Europe
title_full Forecasting the Effects of the New SARS-CoV-2 Variant in Europe
title_fullStr Forecasting the Effects of the New SARS-CoV-2 Variant in Europe
title_full_unstemmed Forecasting the Effects of the New SARS-CoV-2 Variant in Europe
title_short Forecasting the Effects of the New SARS-CoV-2 Variant in Europe
title_sort forecasting the effects of the new sars-cov-2 variant in europe
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106412/
https://www.ncbi.nlm.nih.gov/pubmed/34012360
http://dx.doi.org/10.1155/2021/5553240
work_keys_str_mv AT areaivan forecastingtheeffectsofthenewsarscov2variantineurope
AT nietojuanj forecastingtheeffectsofthenewsarscov2variantineurope

Ejemplares similares